4.3 Article

Non-recovery of ACT in a patient with heparin-induced thrombocytopenia type II during mitral valve replacement using argatroban anticoagulation

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?

Fabrizio Follis et al.

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2010)

Article Pharmacology & Pharmacy

Reduced argatroban doses after coronary artery bypass graft surgery

William D. Hoffman et al.

ANNALS OF PHARMACOTHERAPY (2008)

Article Cardiac & Cardiovascular Systems

Use of Argatroban for anticoagulation during cardiopulmonary bypass in a patient with heparin allergy

Alan I. Smith et al.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2008)

Article Critical Care Medicine

Argatroban Anticoagulation in Intensive Care Patients: Effects of Heart Failure and Multiple Organ System Failure

Susan M. Begelman et al.

JOURNAL OF INTENSIVE CARE MEDICINE (2008)

Article Pharmacology & Pharmacy

Argatroban anticoagulation in critically ill patients

Martin Beiderlinden et al.

ANNALS OF PHARMACOTHERAPY (2007)

Article Critical Care Medicine

Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction

Robert L. Levine et al.

Article Pharmacology & Pharmacy

Effect of renal function on the pharmacodynamics of argatroban

PA Arpino et al.

ANNALS OF PHARMACOTHERAPY (2004)

Article Pharmacology & Pharmacy

Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD

WE Dager et al.

ANNALS OF PHARMACOTHERAPY (2003)

Article Cardiac & Cardiovascular Systems

The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations

K Furukawa et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2001)